John Mulcahy
Chief Executive Officer at SiteOne Therapeutics, Inc.
John Mulcahy active positions
Companies | Position | Start | End |
---|---|---|---|
SiteOne Therapeutics, Inc.
SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT. | Chief Executive Officer | 2021-03-22 | - |
Founder | 2009-12-31 | - | |
President | 2021-03-22 | - | |
Chief Tech/Sci/R&D Officer | 2009-12-31 | 2021-03-22 |
Career history of John Mulcahy
Training of John Mulcahy
Harvard University | Undergraduate Degree |
Stanford University | Doctorate Degree |
Statistics
International
United States | 4 |
Operational
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoral
Consumer Services | 3 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
SiteOne Therapeutics, Inc.
SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT. | Health Technology |
- Stock Market
- Insiders
- John Mulcahy
- Experience